ATE419361T1 - Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus - Google Patents

Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus

Info

Publication number
ATE419361T1
ATE419361T1 AT97920721T AT97920721T ATE419361T1 AT E419361 T1 ATE419361 T1 AT E419361T1 AT 97920721 T AT97920721 T AT 97920721T AT 97920721 T AT97920721 T AT 97920721T AT E419361 T1 ATE419361 T1 AT E419361T1
Authority
AT
Austria
Prior art keywords
antigen
monoclonal antibodies
hcv
molecules
hepatitis
Prior art date
Application number
AT97920721T
Other languages
English (en)
Inventor
Mats Axel Atterdag Persson
Tobias Erik Allander
Original Assignee
Molecules Of Man Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/635,109 external-priority patent/US6538114B1/en
Application filed by Molecules Of Man Ab filed Critical Molecules Of Man Ab
Application granted granted Critical
Publication of ATE419361T1 publication Critical patent/ATE419361T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97920721T 1996-04-19 1997-04-18 Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus ATE419361T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/635,109 US6538114B1 (en) 1996-04-19 1996-04-19 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
US08/844,215 US6747136B2 (en) 1996-04-19 1997-04-17 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen

Publications (1)

Publication Number Publication Date
ATE419361T1 true ATE419361T1 (de) 2009-01-15

Family

ID=27092301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920721T ATE419361T1 (de) 1996-04-19 1997-04-18 Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus

Country Status (8)

Country Link
US (1) US6747136B2 (de)
EP (1) EP0937153B1 (de)
AT (1) ATE419361T1 (de)
CA (1) CA2262423C (de)
DE (1) DE69739187D1 (de)
DK (1) DK0937153T3 (de)
ES (1) ES2320051T3 (de)
WO (1) WO1997040176A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4593783B2 (ja) * 1998-07-21 2010-12-08 ゲンマブ・アクティーゼルスカブ 抗ｃ型肝炎ウイルス抗体およびその使用
AU1462300A (en) 1998-11-05 2000-05-22 Board Of Trustees Of The Leland Stanford Junior University Human pan-hcv human monoclonal antibodies
US7091324B2 (en) * 1998-11-05 2006-08-15 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
ES2279766T3 (es) * 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
IL137522A (en) * 2000-07-26 2007-06-17 Drk Blutspendediendst Baden Wu Human monoclonal antibody against hepatitis c virus e2 glycoprotein
EP1355947A2 (de) 2000-12-01 2003-10-29 The Government of the United States of America, as Represented by the Secretary, Department of Health and Human Services Monoklonale antikörper spezifisch für das e2-glykoprotein von hepatitis c virus, und deren verwendung in der diagnose, behandlung und vorbeugung von hepatitis c
WO2002061071A2 (en) * 2000-12-18 2002-08-08 Dyax Corp. Focused libraries of genetic packages
EP1355948B1 (de) 2001-01-12 2009-03-11 Molecules of Man AB Materialien und methoden zur behandlung von hepatitis c
WO2002059340A1 (en) * 2001-01-26 2002-08-01 The Scripps Research Institute Immunopolypeptides to hepatitis c virus
US20070178065A1 (en) * 2002-05-03 2007-08-02 Lattime Edmund C Neutralizing factors as vaccine adjuvants
WO2004027028A2 (en) * 2002-09-18 2004-04-01 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
JP5642972B2 (ja) 2007-02-21 2014-12-17 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ Ｃ型肝炎ウイルス（ｈｃｖ）に対するヒト抗体およびその使用
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
WO2011147863A1 (en) 2010-05-25 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
CN114920836B (zh) * 2021-05-08 2024-03-29 南昌大学 一种高亲和力抗丙型肝炎病毒的全人源单克隆抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308750A (en) 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
EP0447984A1 (de) 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
FR2677372B1 (fr) * 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
EP0605522B1 (de) 1991-09-23 1999-06-23 Medical Research Council Methoden zur Herstellung humanisierter Antikörper

Also Published As

Publication number Publication date
US20020016445A1 (en) 2002-02-07
EP0937153B1 (de) 2008-12-31
ES2320051T3 (es) 2009-05-18
CA2262423C (en) 2010-08-03
DE69739187D1 (de) 2009-02-12
CA2262423A1 (en) 1997-10-30
EP0937153A1 (de) 1999-08-25
US6747136B2 (en) 2004-06-08
WO1997040176A1 (en) 1997-10-30
DK0937153T3 (da) 2009-05-04

Similar Documents

Publication Publication Date Title
ATE419361T1 (de) Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus
ATE425989T1 (de) Proteinreinigungsverfahren
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE59109271D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
AU2001294541A1 (en) Mammalian genes; related reagents and methods
DE69936105D1 (de) Menschliche tslp nukleinsäuren und polypeptide
AU6135101A (en) Mammalian receptor proteins; related reagents and methods
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE148168T1 (de) Monoklonale antikörper
ATE370235T1 (de) Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
KR960705038A (ko) 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease)
DE69535789D1 (de) Il-2r-assoziiertes polypeptid und dafür kodierende dna-molekülen
DE69435059D1 (de) Immunoreaktive antigene des hepatitis e viruses
DK1181366T4 (da) Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
Dehghanpisheh et al. Retrovirally induced mouse anti‐TCR monoclonals can synergize the in vitro proliferative T cell response to bacterial superantigens
Michiyo et al. Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
BR0204599A (pt) Sequências de proteìna de núcleo de hcv
Wasniowska et al. An immunoblotting procedure for screening glycophorins and band 3 protein in the same blots: Identification of glycophorin and band 3 variant forms
Grossberg Studies on Binding Sites of Myeloma Proteins
Odjakova et al. Study on the antigen specificity of autoantibodies in Sera of patients with colagenoses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties